Raising Money for
2014 MRF Research Grantee
Cell Innovations, Australia
A randomized, placebo-controlled, double-blind, proof-of-concept study of the safety and efficacy of autologous stromal vascular fraction cells, in patients with moderate to severe chronic migraine headache
Testing whether Stromal Vascular Fraction stem cell therapy will significantly decrease the frequency and severity of chronic migraines.